Oramed Pharmaceutical Inc. Technology and Politics Essay -- Business A

Oramed Pharmaceutical Inc. TechnologyOramed is a contemporary pharmaceutical comp whatsoever that is mainly concentrate into developing new head medicinal diabetic do drugss that have not been in existence before. Similar to other pharmaceutical companies, technology is a key factor in the advantage such companies. In an exclusive interview on www.wallst.net with Nadav Kidron, Orameds CEO, he was quoted describing Oramed Pharmaceuticals Inc. as an Israeli company focused on the development of oral rake solutions based on proprietary technology (PR Newswire Association LLC, 2007). Kidrons comment demonstrates the value of technology to Oramed causing the company to patent its technology and fruit. Lately Oramed focused on the development of a new diabetic drug called ORMD0801. This product, in a form of a gel capsule, can be consumed orally. ORMD0801 in turn, plays a role in eliminating the fill for insulin delivery by the means of self-injecting and constant painful testing of i nsulin blood levels. In order to accomplish this function, Oramed will need sophisticated technology and certainly top-notch high-tech equipment. Therefore, Oramed has to in an ongoing basis to secure in-licensing and other means of obtaining additional technologies to complement and/or expand its product portfolio (The New York Times, 2012).Orameds emerging ORMD0801 delivery is a technology in its-self. It advances the ability of the body to absorb peptides and proteins through the intestinal track wall without creating any changes to the active ingredients of the drug (Oramed, 2009). This was possible by introducing a substitute drug delivery system (Oramed Pharmaceuticals Inc., 2010). This delivery system will successfully deliver the drug to ... ...012/03/20/idUS125396+20-Mar-2012+BW20120320 PR Newswire Association LLC. (2007). Exclusive Interview With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.Wallst.Net. PR Newswire. ProQuest Newsstand. http//proquest.umi.com/pqd link?vinst=PROD&fmt=3&startpage=-1&vname=PQD&RQT=309&did=1256371181&scaling=FULL&vtype=PQD&rqt=309&TS=1333335886&clientId=20655PR Newswire Association LLC. (2009). Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award. PR Newswire. http//proquest.umi.com.ezproxy.liberty.edu2048/pqdlink?vinst=PROD&fmt=3&startpage=1&vname=PQD&RQT=309&did=1844533951&scaling=FULL&vtype=PQD&rqt=309&TS=1333049930&clientId=20655The New York Times. (2012). Business Day. Retrieved from NY Times.com http//topics.nytimes.com/top/ discussion/business/companies/oramed-pharmaceuticals-inc/index.html